【Introduction】 Since 2000, E. coli and other Enterobacteriaceae species producing CTX-M-type ESBLs (CTX-M) have been commonly isolated from community-acquired.

Slides:



Advertisements
Similar presentations
Dangerous Dublin: The Virulent Salmonella Colette O’ Hare 1, Conor Burke 2, Suzanne Gray 3, Niall Delappe 1, Ger Doran 1, Grainne McHale 2, Dr. Gerard.
Advertisements

Prevalence of ESBL and MBL antibiotic resistance genes in Klebsiella pneumoniae in Pretoria Academic Hospital Maningi NE, Ehlers MM, Hoosen AA, Makgothlo.
Emerging Antimicrobial Resistance in Texas The new ESBLs.
CRE Surveillance Activities
2009 CLSI M100-S19 Update Nebraska Public Health Laboratory.
Methods for detection β-lactamases Sarah Alharbi.
Results (cont.) Figure 3: Gel results checking for digested DNA fragments using the EcoR1 restriction enzyme. (A) Lane 1 shows blue colony obtained from.
New Resistance in Gram Negative Rods (GNRs)
Resistance to  -lactam antibiotics within the Enterobacteriaceae Paul D. Fey, Ph. D. University of Nebraska Medical Center.
Methods Revised Abstract Methods Results TP-271 is a Potent, Broad-Spectrum Fluorocycline with Activity Against Community-Acquired Bacterial Respiratory.
Salmonella Typhimurium DT104: to b or not to b Geraldine Doran, Niall DeLappe, Colette O Hare, Geraldine Corbett-Feeney, Martin G. Cormican. National Salmonella.
Ceftazidime resistance in a Salmonella enterica serotype Bareilly in Ireland N.DeLappe, D Morris, C.O’Hare, E.Costello, G.Corbett-Feeney and M.Cormican.
The Antibiotic Sensitivity Test Presented by Marian Mikhail Undergraduate student Biology Major Health and Science Concentration Health and Science Concentration.
Mechanisms of Antimicrobial Resistance Jing-Jou Yan, M.D. Department of Pathology National Cheng Kung University Hospital 26/12/2007.
E. coli, K. pneumoniae and P. mirabilis accounted for more than 25% of all bacterial samples isolated from the Asian-Pacific region. The ESBL phenotype.
Aims of study This surveillance study was performed to determine the in vitro activity of ciprofloxacin against clinical isolates of Escherichia coli and.
U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only.
Salmonella enterica Bredeney: Third commonest cause of human infection in Ireland in 1999 C. A. O’ Hare, M. Cormican. G. Corbett-Feeney, S. Fanning and.
Salmonella Reference Laboratory Epidemiology of Salmonella enterica from C. O’ Hare 1, N. Delappe 1, G. Doran 1, D. Morris 2, D. Kilmartin 2,
U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only.
ESBL, AmpC -lactamase 표준진단법
Outbreak of USA300-like MRSA colonization in a postpartum maternal and neonatal care center in Korea Misuk Ji 1*, Heungsup Sung 1, Ai-rhan Kim 2, Mi-Na.
Prof KN Prasad, MD Department of Microbiology,
Materials & Methods Objective Extraintestinal pathogenic Escherichia coli in healthy broiler chicken in Italy: a combination of virulence with antibiotic.
MRSA, ESBLs and Carbapenem Resistance
C-158 Genetic and Biochemical Characterisation of OXA-405, a New Extended Spectrum Class D -Lactamase from Serratia marcescens L. Dortet1,2, S. Oueslati1,
Tapasyapreeti Mukhopadhyay, Vrushali Patwardhan, Sarman Singh
2. Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA
Characterization of B-lactam resistance mechanisms among UTI isolates collected from women attending primary care across Europe- RGNOSIS P th ECCMID.
Current Status of Antimicrobial Resistance
N°XXXX Rapid detection of extended-spectrum BETA-lactamase producing Enterobacteriaceae from urine using the ESBL NDP test Patrice Nordmann, Laurent Poirel,
Serotypes, genotypes and antimicrobial resistance patterns of human diarrhoeagenic Escherichia coli isolates circulating in southeastern China  Y. Chen,
Can efflux confer high levels resistance to meropenem (MEM) in Pseudomonas aeruginosa (Pa) clinical isolates? H. Chalhoub1, H. Rodriguez-Villalobos2,
15th International Symposium on Staphylococci and Staphylococcal Infections 26th-30th August 2012 Lyon, France Prevalence and mechanism of resistance.
Phenotypic and genotypic typing of Salmonella enterica serovar Enteritidis isolates from poultry farms in Tunisia Guedda Intissar1, Abbassi Mohamed Salah1,
Figure 1 Principle coordinates analysis plot for 127 Escherichia coli isolates from the SENTRY and Meropenem Yearly Susceptibility Test Information Collection.
High Fecal Carriage of Antibiotic Resistant Enterobacteriaceae Strains among Food Handlers in the West Coast Region of The Gambia Bakary Sanneh1*, Olliemattou.
Introduction and Purpose References and Acknowledgements
Frequencies of detected ARGs
carbapenemase-positive Enterobacteriaceae
Emergence of Klebsiella pneumoniae with an AmpC(DHA-1) and blaSHV-11 in a Belgian hospital. Timothy Vanwynsberghe1, Katia Verhamme2, Marijke Raymaekers3,
REDUCED RATES OF VANCOMYCIN RESISTANT ENTEROCOCCI (VRE) COLONIZATION
Environmental stress exacerbate the emergence of Multidrug
Clinico-Pathological Conference (CPC) Meet
Antibiotics sensitivity of microorganism causing nosocomial infections
NDM-1 could still evolve:
Prevalence of CTX-M-14 type in Welsh Hospitals
Table 1: Resistance profile
Figure 1. Molecular modeling of : a) GES-1 and b) GES-1P174E
Antibiogram By:Dr. S. S. Khoramrooz In the name of God
Sporadic occurrence of CMY-2-producing multidrug-resistant Escherichia coli of ST- complexes 38 and 448, and ST131 in Norway  U. Naseer, B. Haldorsen,
C th Interscience Conference on Antimicrobial Agents and Chemotherapy October 25-28, Washington, DC Examining Temocillin Activity in Combination.
C th Interscience Conference on Antimicrobial Agents and Chemotherapy October 25-28, Washington, USA Emergence of VIM-2 Metallo--lactamase.
Dice (Tol 1.0%–1.0%) (H>0.0 % S>0.0%)
Rapid detection of enterobacteriaceae producing extended spectrum beta-lactamases directly from positive blood cultures by matrix-assisted laser desorption.
Evaluation of a diagnostic flow chart for detection and confirmation of extended spectrum β-lactamases (ESBL) in Enterobacteriaceae  S. Polsfuss, G.V.
Extended-spectrum β-lactamase-producing and AmpC-producing Escherichia coli from livestock and companion animals, and their putative impact on public.
Phenotypic detection of extended-spectrum β-lactamase production in Enterobacteriaceae: review and bench guide  L. Drieux, F. Brossier, W. Sougakoff,
Prevalence of extended-spectrum β-lactamases in isolates of the Enterobacter cloacae complex from German hospitals  H. Hoffmann, E. Stürenburg, J. Heesemann,
TRAINING PRESENTATION
C. Varela, A. Oliver, T.M. Coque, F. Baquero, R. Canton 
Ciprofloxacin-resistant, CTX-M-15-producing Escherichia coli ST131 clone in extraintestinal infections in Italy  M. Cerquetti, M. Giufrè, A. García-Fernández,
Mechanisms of Resistance and Clinical Relevance of Resistance to β-Lactams, Glycopeptides, and Fluoroquinolones  Louis B. Rice, MD  Mayo Clinic Proceedings 
I. Faria-Ramos, M. J. Espinar, R. Rocha, J. Santos-Antunes, A. G
Faecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae is common 12 months after infection and is related to strain factors  E.
Emergence of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae during the years 2000 and 2004 in Helsinki, Finland  S.D.
Colonization of residents and staff of a long-term-care facility and adjacent acute-care hospital geriatric unit by multiresistant bacteria  A. March,
Predominance of SHV-5 β-lactamase in enteric bacteria causing community-acquired urinary tract infections in Bosnia and Herzegovina  S. Uzunovic-Kamberovic,
EARS-Net results 2011 Ole Heuer
Serotypes, genotypes and antimicrobial resistance patterns of human diarrhoeagenic Escherichia coli isolates circulating in southeastern China  Y. Chen,
Presentation transcript:

【Introduction】 Since 2000, E. coli and other Enterobacteriaceae species producing CTX-M-type ESBLs (CTX-M) have been commonly isolated from community-acquired extraintestinal infections in humans and their companion animals and from food-producing animals worldwide (Carattoli 2008). The blaCTX-M-related genes were transferred separately to plasmids including complex class 1 integrons and transposons from chromosomes of different Kluyvera species (i.e., K. ascorbata, K. cryocrescens, K. georgiana); thereby, CTX-M has derived in five CTX-M clusters (CTX-M-1/-2/-8/-9/-25) from base sequence homology (Cantón et al. 2012). CTX-M confers resistance against penicillins, oxyimino-cephalosporins, and monobactams (Bonnet 2004).

Hierarchical function Spread chromosome Fig. Hierarchical complexity of blaCTX-M genes within genetic structure and bacterial clones participation in the mobilization, spread, and maintenance Spread Plasmid Spread Insertion sequence and CTX-M gene Class1 Integron Transposon Mobilization and expression Maintenance

【Background】 Plasmidic CMY-2, derived from the AmpC β-lactamase of Citrobacter freundii, and the dominant AmpC β-lactamase among Enterobacteriaceae (Salmonella enterica) in humans and animals worldwide (Tamang et al. 2012) CMY-type β-lactamases, cephamycinases that confer resistance to cephamycins and oxyimino-cephalosporins 【Aims】 to determine the herd prevalence of Enterobacteriaceae producing CTX-M and CMY among numerous dairy farms in Japan to evaluate the genetic relatedness among E. coli isolates derived from dairy cattle by serotyping, multilocus sequence typing (MLST) and pulsed-field gel electrophoresis (PFGE)

【Materials and methods】 A total of 897 faecal samples: each of 897 cattle on a total of 381 dairy farms localized in Nemuro Subprefecture of Hokkaido Prefecture, Japan, between May and Dec. in 2007, and between July and Dec. in 2009 Identification: ID 32 E API system (Sysmex bioMérieux) A total of 250 isolates → CLSI combination disc ESBL confirmatory tests (CLSI 2008) and a chromogenic oxyimino-cephalosporins hydrolysis test (Cica-β-test I; Kanto Chemical, Tokyo, Japan) to detect ESBLs, plasmidic AmpC β-lactamases and metallo-β-lactamases (MBL) Screening for MBL: Sodium mercaptoacetic acid (SMA) double-disc synergy test (SMA-test) : using 1 SMA and The 897 cattle: 550 calves (< 12 months old), 80 heifers (≥ 12 months old to first parturition) and 267 cows Culture: directly streak 50 μg faeces onto a BTB lactose agar plate containing 2 μg ml-1 cefotaxime and 8 μg ml-1  vancomycin → Incubation: 35°C for 40 h (Shiraki et al. 2004) The cattle affected by diarrhoea or dictyocauliasis 2 CAZ discs (Eiken Chemical, Tokyo, Japan) Screening for ESBLs Faecal samples 【Materials and methods】

【Materials and method】 Isolates positive for the ESBL confirmatory tests and/or the Cica-β-test, and the SMA-test-negative The blaTEM and blaSHV genes: PCR using grpou-specific primers (Kojima) and bidirectional sequencing For the CTX-M-positive isolates: PCR and bidirectional sequencing using group-specific PCR primers for blaCTX-M-1 group (Mena et al. 2006), blaCTX-M-2 group and blaCTX-M-9 group (Kojima et al. 2005) For the AmpC-positive isolates : PCR using type-specific primers (blaCMY-1 and blaCMY-2 genes) (Kojima)  Serotyped of E. coli (O and H antigens): pathogenic E. coli antisera ‘SEIKEN’ Set 1 for O antigens, Set 2 for H antigens (Denka Seiken, Tokyo, Japan) Multiplex PCR for the presence of blaCTX-M genes (Xu et al. 2007), and plasmid-mediated AmpC β-lactamase genes (i.e., CMY, ACC, FOX, MOX, DHA, CIT, and EBC groups) (Pérez-Pérez and Hanson 2002) MLST: protocols and database on the E. coli MLST website (http://mlst.ucc.ie/mlst/dbs/Ecoli) PCR and sequencing for ESBLs and AmpC Serotyping and MLST of E. coli     【Materials and method】

【Materials and methods】 PFGE: the PulseNet standardized laboratory protocol (CDC 2004).                                      Restriction enzyme: Xba I or Bln I (Roche Applied Science, Mannheim, Germany)                                         CHEF-DR III electrophoresis systems (Bio-Rad, Hercules, CA, USA) Disc diffusion: cefoxitin, kanamycin, chloramphenicol and levofloxacin (CLSI 2008 and 2011) Dendrogram of the combined PFGE patterns of Xba I and BlnI: BioNumerics software version 5·1 (Applied Maths, Austin, TX, USA) MICs of 23 antimicrobial by broth microdilution: customer-designed, microtiter panel (Opt Panel MP; Kyokuto Pharmaceutical Tokyo, Japan) (CLSI 2008 and 2011) The breakpoints for veterinary pathogens were used for 12 antimicrobial agents (CLSI 2008).  The breakpoints for human Enterobacteriaceae isolates were used for 12 antimicrobial agents (CLSI 2011). E. coli ATCC25922 and Pseudomonas aeruginosa ATCC27853 were used as quality-control strains.   Antimicrobial susceptibility tests PFGE of E. coli       【Materials and methods】

Table 4 CTX-M, TEM, SHV and ST of 23 E. coli strains CTX-M, TEM, and SHV genes n E. Coli MLST (18 STs) CTX-M-15 4 394 744 1167 1266 CTX-M-15+TEM-1 3 540 2325 CTX-M-15+CMY-2+TEM-1 1 CTX-M-2 5 10 (n=3) 48(STC10) 2324 CTX-M-2+TEM-1 58 CTX-M-2+SHV-11 2437 CTX-M-2+CMY-2 46 CTX-M-2+CMY-2+SHV-11 44(STC10) CTX-M-14+TEM-1 10 57 69 CTX-M-14+CMY-2+TEM-1 88 CMY-2 1284 CMY-2+TEM-1 2438

【 Results】 Incidence of isolation and herd prevalence of CTX-M and CMY-2   28 Enterobacteriaceae strains producing CTX-M-15/2/14 and/or CMY-2 were isolated from 28 (3·1 %) of the 897 fecal samples from 20 dairy farms. ① blaCTX-M-15 : 7 E. coli isolates (25·0 %)       ② blaCTX-M-2: 12 isolates (42·9 %; 7 E. coli; 3 K. pneumoniae,     1 Enterobacter cloacae, 1 Citrobacter freundii)   ③ blaCTX-M-14; 3 E. coli isolates (10·7 %)   ④ 6 E. coli isolates (21.4%): blaCMY-2 and/or blaCTX-M-2/15/14     12 of 23 E. coli (52.2%): blaTEM-1 or blaSHV-11 4 (50%) of 8 CTX-M-15–producing E. coli:blaTEM-1  MLST, serotyping and PFGE of 23 E. coli isolates   23 E. coli isolates → 18 STs/ 21 PFGE types No predominant E. coli strain of a particular ST/PFGE type/serotype was shown in one farm and among the farms. 

【 Results】 Antimicrobial susceptibility and antimicrobial use CTX-M-2/14 producers showed high susceptibility rates to CAZ, cefmetazole (CMZ), moxalactam, carbapenems, gentamicin (GEN), amikacin (AMK) and fluoroquinolones (FQs). MICs for CAZ CMZ, enrofloxacin and ciprofloxacin were higher for the E. coli isolates producing CTX-M-15 and CMY-2 than for the isolates producing CTX-M-2/14. Between 2006 and 2010, our veterinary clinics used 2,016 daily doses of ceftiofur and 1,408 daily doses of enrofloxacin (based on the weight of an adult cow) per year for approximately130,000 cows. The spread of blaCTX-M/CMY-2 may be due to the frequent use of mastitis preparations consisting of 1st-, 2nd-generation cephalosporins and using waste milk mixed with cephalosporins to feed calves.

【Conclusion】 【 Significance and impact of study 】 Three clusters of CTX-M (CTX-M-15, CTX-M-2, CTX-M-14) had spread among Japanese dairy farms. The incidence of isolation of E. coli and 3 genera of Enterobacteriaceae producing CTX-M-15/2/14 and/or CMY-2 in bovine faeces was 28 (3·1 %) of the 897 fecal samples. The herd prevalence of these Enterobacteriaceae was 20 (5·2 %) of the 381 dairy farms. The 23 E. coli isolates showed clonal diversity, as assessed by MLST analysis and PFGE typing. The 8 E. coli isolates producing CTX-M-15 belonged to 6 STs and most harbored TEM-1 and were resistant to CAZ and FQs. This is the first report on the prevalence of multidrug-resistant CTX-M-15–producing E. coli among Japanese dairy farms. 【 Significance and impact of study 】

【References】 Bonnet, R. (2004) Growing group of extended-spectrum β-lactamases: the CTX-M enzymes. Antimicrob Agents Chemother 48, 1–14. Canton, R., González-Alba, J.M. and Galán J.C. (2012) CTX-M enzymes: origin and diffusion. Front Microbial 3, article 110. (1–19) Carattoli, A. (2008) Animal reservoirs for extended spectrum β-lactamase producers. Clin Microbiol Infect 14 (Suppl 1), 117– 123. Centers for Disease Control and Prevention (CDC). (2004) One-day (24-28 h) standardized laboratory protocol for molecular  subtyping of Escherichia coli O157:H7, non-typhoidal Salmonella serotypes, and Shigella sonnei by pulsed field gel electrophoresis (PFGE). Sections 5.1, 5.2, 5.4. Atlanta, GA: CDC Clinical and Laboratory Standards Institute (CLSI). (2008) Performance Standards for Antimicrobial Disk and Dilution    Susceptibility Tests for Bacteria Isolated from Animals; Approved Standard, 3rd edn, M31-A3. Wayne, PA: CLSI. Clinical and Laboratory Standards Institute (CLSI). (2011) Performance Standards for Antimicrobial Susceptibility Testing, 21st Informational Supplement, M100-S21. Wayne, PA: CLSI. Kojima, A., Ishii, Y., Ishihara, K., Esaki, H., Asai, T., Oda, C., Tamura, Y., Takahashi, T. and Yamaguchi, K. (2005)  Extended-spectrum-β-lactamase-producing Escherichia coli strains isolated from farm animals from 1999 to 2002: Report from the Japanese Veterinary Antimicrobial Resistance Monitoring Program. Antimicrob Agents Chemother 49, 3533−3537. Mena A., Plasencia V., Garcia L., Hidalgo O., Avestarán J.I., Alberti S., Borrell N., Pérez J.L. and Oliver A. (2006)  Characterization of a large outbreak by CTX-M-1-producing Klebsiella pneumoniae and mechanisms leading to in vivo carbapenem resistance development. J Clin Microbiol 44, 2831−2837. Pérez-Pérez F.J. and Hanson N.D. (2002) Detection of plasmid-mediated AmpC β-lactamase genes in clinical isolates by using  multiplex PCR. J Clin Microbiol 40, 2153−62. Shiraki, Y., Shibata, N., Doi, Y. and Arakawa, Y. (2004) Escherichia coli producing CTX-M-2 β-lactamase in cattle, Japan. Emerg Infect Dis 10, 69−75. Tamang, M.D., Nam, H.-M., Jang, G.-C. Kim, S.-R., Chae, M.H., Jung, S.-C., Byun, J.-W. Park, Y.H. and Lim, S.-K. (2012)  Molecular characterization of extended-spectrum-β-lactamase-producing and plasmid-mediated AmpC β-lactamase- producing Escherichia coli isolated from stray dogs in South Korea. Antimicrob Agents Chemother 56, 2705–2712. Xu, L., Ensor, V., Gossain, S., Nye, K. and Hawkey, P. (2007) Rapid and simple detection of blaCTX-M genes by multiplex PCR assay. J Med Microbiol 54, 1183–1187.

Sample: Accepted-paper Ohnishi M, Okatani AT, Esaki H, Harada K, Sawada T, Murakami M, Marumo K, Kato Y, Sato R, Shimura K, Hatanaka N, Takahashi T. 2013. Herd Prevalence of Enterobacteriaceae producing CTX-M-type and CMY-2 β-lactamases among Japanese dairy farms. J. Appl. Microbiol. 115:xx-xx Sample: Accepted-paper